See more : StoneBridge Acquisition Corporation (APACU) Income Statement Analysis – Financial Results
Complete financial analysis of Avenir Wellness Solutions, Inc. (AVRW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Avenir Wellness Solutions, Inc., a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- Yunnan Yunwei Company Limited (600725.SS) Income Statement Analysis – Financial Results
- Shervani Industrial Syndicate Limited (SHERVANI.BO) Income Statement Analysis – Financial Results
- ATWEC Technologies, Inc. (ATWT) Income Statement Analysis – Financial Results
- Studio Retail Group plc (STU.L) Income Statement Analysis – Financial Results
- United Corporations Limited (UCPLF) Income Statement Analysis – Financial Results
Avenir Wellness Solutions, Inc. (AVRW)
About Avenir Wellness Solutions, Inc.
Avenir Wellness Solutions, Inc., through its subsidiary The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve efficacy and enhance wellness. It provides its products in beauty, health and wellness, and pet care categories under the Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips brand names. The company sells its products through drug and grocery chains, convenience stores, and mass retailers. It also offers its products under private label to retailers and multi-level marketers, as well as DTC, via online website orders, including opt-in subscriptions. The company was formerly known as CURE Pharmaceutical Holding Corp. and changed its name to Avenir Wellness Solutions, Inc. in October 2022. Avenir Wellness Solutions, Inc. was incorporated in 2014 and is headquartered in Sherman Oaks, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 4.35M | 4.90M | 6.08M | 2.05M | 623.00K |
| Cost of Revenue | 1.24M | 1.56M | 1.75M | 1.08M | 231.00K |
| Gross Profit | 3.11M | 3.34M | 4.33M | 975.00K | 392.00K |
| Gross Profit Ratio | 71.52% | 68.20% | 71.22% | 47.54% | 62.92% |
| Research & Development | 0.00 | 492.00K | 2.37M | 2.79M | 2.31M |
| General & Administrative | 6.26M | 7.94M | 11.29M | 11.37M | 9.32M |
| Selling & Marketing | 2.81M | 2.23M | 2.90M | 1.10M | 500.00K |
| SG&A | 9.07M | 10.17M | 14.19M | 11.37M | 9.82M |
| Other Expenses | -451.00K | 99.00K | 2.43M | 61.00K | -575.00K |
| Operating Expenses | 8.62M | 11.73M | 16.50M | 14.15M | 1.73M |
| Cost & Expenses | 9.85M | 13.28M | 18.25M | 15.23M | 1.73M |
| Interest Income | 52.00K | 51.00K | 62.00K | 37.00K | 57.00K |
| Interest Expense | 57.00K | 465.00K | 640.00K | 2.47M | 4.11M |
| Depreciation & Amortization | 183.00K | 1.58M | 2.41M | 918.00K | 579.00K |
| EBITDA | -3.20M | -16.46M | -5.53M | -27.22M | -16.64M |
| EBITDA Ratio | -73.64% | -135.99% | -119.41% | -593.03% | -278.17% |
| Operating Income | -5.51M | -18.27M | -10.39M | -18.96M | -1.73M |
| Operating Income Ratio | -126.66% | -373.16% | -170.98% | -924.33% | -278.17% |
| Total Other Income/Expenses | 2.07M | -228.00K | 1.81M | -11.66M | -7.68M |
| Income Before Tax | -3.44M | -18.50M | -8.58M | -30.62M | -21.37M |
| Income Before Tax Ratio | -79.16% | -377.82% | -141.15% | -1,492.98% | -3,430.66% |
| Income Tax Expense | 3.00K | 42.00K | 7.69M | 2.53M | 9.41M |
| Net Income | -3.44M | -25.51M | -13.19M | -30.62M | -21.36M |
| Net Income Ratio | -79.23% | -521.02% | -217.06% | -1,492.98% | -3,429.05% |
| EPS | -0.05 | -0.36 | -0.21 | -0.65 | -0.45 |
| EPS Diluted | -0.05 | -0.36 | -0.21 | -0.65 | -0.45 |
| Weighted Avg Shares Out | 72.09M | 70.21M | 62.35M | 47.31M | 47.31M |
| Weighted Avg Shares Out (Dil) | 72.09M | 70.21M | 62.35M | 47.31M | 47.31M |
Avenir Wellness Solutions Reports Fourth Quarter 2023 Results
Avenir Wellness Solutions Reports Third Quarter 2023 Results
Avenir Wellness Solutions Announces Return of Stock Trading Back to OTCQB Market
Source: https://incomestatements.info
Category: Stock Reports